Alcon [ALC] vs Hologic [HOLX] Detailed Stock Comparison

Alcon

NYSE
Loading...

Hologic

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Alcon wins in 5 metrics, Hologic wins in 14 metrics, with 0 ties. Hologic appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricAlconHologicBetter
P/E Ratio (TTM)40.8427.86Hologic
Price-to-Book Ratio2.073.08Alcon
Debt-to-Equity Ratio23.6352.09Alcon
PEG Ratio26.115.78Hologic
EV/EBITDA21.1612.47Hologic
Profit Margin (TTM)11.28%13.79%Hologic
Operating Margin (TTM)13.30%25.48%Hologic
EBITDA Margin (TTM)13.30%25.48%Hologic
Return on Equity5.23%11.38%Hologic
Return on Assets (TTM)2.74%6.69%Hologic
Free Cash Flow (TTM)$1.41B$1.15BAlcon
1-Year Return-22.78%-15.37%Hologic
Price-to-Sales Ratio (TTM)4.623.70Hologic
Enterprise Value$49.36B$15.57BAlcon
EV/Revenue Ratio4.973.86Hologic
Gross Profit Margin (TTM)55.92%56.32%Hologic
Revenue per Share (TTM)$20$18Alcon
Earnings per Share (Diluted)$2.25$2.41Hologic
Beta (Stock Volatility)0.700.57Hologic
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Alcon vs Hologic Stock Performance Analysis

Loading Price Chart...

Alcon
Hologic
Alcon Stock Overview | Hologic Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Alcon0.00%2.55%-4.04%-15.89%-18.88%-9.99%
Hologic1.30%3.22%1.95%4.00%12.14%-5.34%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Alcon-22.78%28.31%21.85%37.99%37.99%37.99%
Hologic-15.37%6.51%-2.13%82.16%322.59%379.59%

News Based Sentiment: Alcon vs Hologic

Alcon

News based Sentiment: MIXED

Alcon's recent developments present a mixed picture. While the company exceeded earnings expectations and is pursuing a significant acquisition, lowered revenue guidance and analyst downgrades introduce uncertainty. This combination of positive and negative factors makes October a pivotal month for the company's investment narrative.

View Alcon News Sentiment Analysis

Hologic

News based Sentiment: NEUTRAL

The month's news for Hologic paints a picture of stability rather than dramatic growth. While the stock outperformed the S&P 500 slightly and analyst estimates are trending upward, the overall sentiment is neutral due to the 'Hold' rating and modest gains. The valuation metrics suggest potential value, but don't indicate a strong buy signal.

View Hologic News Sentiment Analysis

Performance & Financial Health Analysis: Alcon vs Hologic

MetricALCHOLX
Market Information
Market Cap i$45.84B$14.94B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i1,498,6803,267,260
90 Day Avg. Volume i1,604,6032,018,787
Last Close$75.11$67.91
52 Week Range$73.21 - $99.48$51.90 - $84.39
% from 52W High-24.50%-19.53%
All-Time High$101.10 (Sep 09, 2024)$87.88 (May 01, 2023)
% from All-Time High-25.71%-22.72%
Growth Metrics
Quarterly Revenue Growth0.01%0.01%
Quarterly Earnings Growth0.41%0.00%
Financial Health
Profit Margin (TTM) i0.11%0.14%
Operating Margin (TTM) i0.13%0.25%
Return on Equity (TTM) i0.05%0.11%
Debt to Equity (MRQ) i23.6352.09
Cash & Liquidity
Book Value per Share (MRQ)$44.39$21.79
Cash per Share (MRQ)$2.85$8.47
Operating Cash Flow (TTM) i$2.12B$1.07B
Levered Free Cash Flow (TTM) i$1.18B$760.11M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i$0.00N/A

Valuation & Enterprise Metrics Analysis: Alcon vs Hologic

MetricALCHOLX
Price Ratios
P/E Ratio (TTM) i40.8427.86
Forward P/E i26.1114.23
PEG Ratio i26.115.78
Price to Sales (TTM) i4.623.70
Price to Book (MRQ) i2.073.08
Market Capitalization
Market Capitalization i$45.84B$14.94B
Enterprise Value i$49.36B$15.57B
Enterprise Value Metrics
Enterprise to Revenue i4.973.86
Enterprise to EBITDA i21.1612.47
Risk & Other Metrics
Beta i0.700.57
Book Value per Share (MRQ) i$44.39$21.79

Financial Statements Comparison: Alcon vs Hologic

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)ALCHOLX
Revenue/Sales i$2.47B$1.01B
Cost of Goods Sold i$1.09B$628.00M
Gross Profit i$1.38B$377.30M
Research & Development i$222.00M$61.50M
Operating Income (EBIT) i$468.00M$37.90M
EBITDA i$463.00M$121.70M
Pre-Tax Income i$414.00M$-28.50M
Income Tax i$64.00M$-11.10M
Net Income (Profit) i$350.00M$-17.40M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)ALCHOLX
Cash & Equivalents i$1.41B$1.43B
Total Current Assets i$6.07B$3.21B
Total Current Liabilities i$2.25B$989.70M
Long-Term Debt i$5.02B$2.47B
Total Shareholders Equity i$22.02B$4.62B
Retained Earnings iN/A$3.03B
Property, Plant & Equipment i$4.90B$939.80M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)ALCHOLX
Operating Cash Flow iN/A$28.40M
Capital Expenditures iN/A$-24.70M
Free Cash Flow i$384.00M$129.20M
Debt Repayment iN/A$-10.20M
Common Stock Repurchase iN/A$-200.00M

Short Interest & Institutional Ownership Analysis

MetricALCHOLX
Shares Short i6.89M3.11M
Short Ratio i4.542.03
Short % of Float iN/A0.02%
Average Daily Volume (10 Day) i1,498,6803,267,260
Average Daily Volume (90 Day) i1,604,6032,018,787
Shares Outstanding i494.62M231.73M
Float Shares i494.60M220.32M
% Held by Insiders i0.00%0.01%
% Held by Institutions i0.69%1.01%

Dividend Analysis & Yield Comparison: Alcon vs Hologic

MetricALCHOLX
Last 12-Month Dividend i$0.00N/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i$0.17N/A
3-Year Avg Dividend Yield i0.30%N/A
3-Year Total Dividends i$0.50N/A
Ex-Dividend DateMay 14, 2024N/A